Unleashing the Digital Biology Revolution
Elsa Sotiriadis
Elsa Sotiriadis is a globetrotting biohacker-turned-futurist and entrepreneur. As director of a VC firm she helped build 25 breakthrough startups to advance innovation in medicine, food, energy and sustainability. Prior to that, she was a lead analyst and management consultant on emerging technologies and co-lead a futurism study. She holds a PhD in Synthetic Biology from Imperial College London, has written for publications like Singularity Hub and tech goes under her skin – she became a ‘cyborg’ live on stage. In her (rare) spare time, she writes science fiction and has published critically acclaimed poetry.
Elsa Sotiriadis reveals how biology is becoming an information technology, usher
The genetic code is open source and accessible to all of us. It can empower us to take charge of our own destiny and our own evolution.
Summary
- Biology is transforming into an information technology where artificial organisms are designed in the cloud, mirroring the early era of personal computing. - Cells function as high-precision manufacturing units that can produce animal-free food, lab-grown fabrics, and fermented products like coffee or milk in breweries. - The precipitous drop in DNA sequencing costs and the rise of CRISPR technology allow for personalized genomics and the ability to edit the genetic source code of the human species. - Biomimicry is becoming a core design principle, leading to innovations like biodegradable algae packaging, furniture grown from mushrooms, and fabrics made from lab-created spider silk. - The democratization of biotech enables biohackers to access open-source genetic tools, potentially shifting the focus from expensive healthcare to individual evolutionary control.
Article
Unleashing The Digital Biology Revolution
At Biohacker Summit 2018 Stockholm, Elsa Sotiriadis Cast Biology As The Next Personal Computer
On Friday, 18 May 2018, at Biohacker Summit 2018 Stockholm in Sweden, Elsa Sotiriadis stepped onto the stage with a proposition that sounded, at first, like science fiction and then, as her argument unfolded, like an imminent civic reality. Biology, she said, was no longer merely something humanity studied. It had become something humanity could program.
Sotiriadis, the futurist, entrepreneur and synthetic biologist, framed her presentation, *Unleashing The Digital Biology Revolution: Biohacking The Future Of Food, Health & Design*, as a defining technological hinge point. Just as computing once shrank from industrial mainframes into personal devices, she argued, biology was undergoing the same collapse in scale, cost and control. “It is as exciting to be in biotech right now as it was to be in the computer industry in the early seventies,” she said. “We are witnessing the exact same thing that made computers personal happening right now in biology.”
It was a striking analogy, but not a casual one. Throughout the talk, Sotiriadis returned to the idea that life itself was becoming an information technology: digitized, democratized and increasingly personalized.
Biology As Software
The force of Sotiriadis’s speech lay in the elegance of its central claim. DNA, in this telling, was code. Cells were factories. Biologists were “the software engineers of life”. A tiny biological instruction set, she suggested, could produce either catastrophe or salvation.
“Biology has become an information technology,” she said. “Just as any other disruptive technology, it is becoming increasingly digitized, democratized, and personalized.”
That sentence served as the spine of the presentation. Sotiriadis described a world in which artificial organisms could be designed in the cloud, tested with computational tools, and then deployed into the material world as products, therapies or sustainable systems. The genetic code was no longer only a scientific mystery. It was becoming a design space.
To make that future feel tangible, she moved quickly from abstraction to example. Chairs might be modeled on biological structures. Wearables might host living microbial systems. DNA might become not only the script of life but also the storage medium for data. Even aesthetics, fashion and architecture, she suggested, would increasingly be shaped by biomimicry and engineered living materials.
The Future Of Food, Brewed Not Farmed
Among the most arresting sections of the talk was Sotiriadis’s account of food as a programmable platform. If cells are “nanoscale, high precision manufacturing units”, then food production could begin to resemble fermentation and software-driven fabrication more than agriculture as it has historically been known.
Her vision was disarmingly vivid: local meat breweries instead of slaughterhouses, microbes fermenting coffee, algae powering protein-rich drinks, and a widening menu of substitutes that were not merely plant-based imitations but biofabricated equivalents. Chicken-free chicken. Egg-free egg whites. Shrimp-free shrimp. Cow-free milk.
What she described was not simply a culinary trend but a reordering of the supply chain itself. In this future, the animal could be engineered out of production. Biology would be domesticated not in the old agricultural sense, but in a new synthetic one, housed in bioreactors, tuned by data and optimized for sustainability.
It was here that Sotiriadis’s broader political point came into focus. The digital biology revolution was not only about invention. It was about decentralization. If food could be brewed locally and biologically, power could move outward from industrial giants toward distributed makers, designers and citizens.
Health At The Molecular Interface
Sotiriadis also turned to medicine, where the stakes of programmability are highest and most intimate. Human beings, she said, were “metamorphosing into living, breathing data sets”, and for the first time had access to molecular tools capable of editing “the source code of our own species”.
CRISPR stood at the center of this argument. It symbolized both astonishing precision and profound unease. Sotiriadis cited developments in accelerated cancer diagnostics, AI-assisted drug discovery, molecular delivery systems and DNA-based data storage, painting a picture of a medical frontier where biology and computation no longer sat side by side but fused into one field.
The dramatic fall in sequencing costs supplied her with the economic logic behind the revolution. The first human genome, she reminded the audience, cost billions of dollars and took more than a decade to sequence. The trajectory since then has been mercilessly downward. As the field moved toward the prospect of the $100 genome, the promise of truly personal genomics appeared less like hype than momentum.
This was not a vision of medicine confined to hospitals. It was a vision of medicine migrating into everyday life: diagnostics in hours rather than days, cellular monitoring, genomically informed interventions and, eventually, implantables that could track the body from within.
Design After Nature
If food and health showed the utility of digital biology, design showed its poetry. Sotiriadis argued that biomimicry would become one of the defining principles of the 21st century, especially as urban populations expanded and environmental pressures intensified.
Her examples were chosen for their tactile strangeness. Biodegradable packaging made from algae. Sneakers derived from fast-growing kelp. Spider-silk-inspired fabrics brewed in bioreactors. Lamps and furniture grown from mushrooms.
These were not presented as novelty objects but as prototypes of a different industrial imagination. Instead of extracting dead matter and forcing it into shape, designers could work with living systems, borrowing nature’s architectures and metabolic efficiencies. Matter itself could become less inert, more regenerative, and more entwined with ecological cycles.
There was a moral undertow here. The old industrial model had too often treated life as a resource to be consumed. The new one, at least in its most hopeful form, treated life as a collaborator.
The New Democratization Of Biotech
Sotiriadis was careful to place biohacking within a wider movement of access. She pointed to open-source tools, student competitions such as iGEM, do-it-yourself CRISPR kits and the growing culture of experimentation beyond formal institutions. Biology, once guarded by elite laboratories and vast capital requirements, was becoming available to smaller actors.
For some, that opening signaled danger. For Sotiriadis, it also signaled agency.
“Welcome to a new era of biotech, when artificial designer organisms become the canvas of human ingenuity and creativity, and exciting new products arise from within the genetic code,” she said.
Her phrase “citizens of biology” captured the political mood of the talk. The future, she implied, would not be shaped only by pharmaceutical giants, state research agencies or technology monopolies. It would also be shaped by communities, tinkerers, startups and individuals willing to engage directly with the tools of life.
That democratization, however, was not offered as uncomplicated liberation. The talk acknowledged the ethical shadows that follow any technology capable of entering the genome, the brain or the workplace.
The Ethical Edge Of A Programmable Species
For every thrilling prospect Sotiriadis described, another seemed to flicker behind it. She invoked companies promising genomic analysis for employers, raising the specter of a new genetic sorting. She mentioned brain preservation ventures whose futuristic premise concealed a lethal present-day reality. She pointed to AI-enabled neural implants being tested for depression, chronic pain and post-traumatic stress disorder, technologies that could heal but also alter the terms of personhood.
This tension gave the presentation its seriousness. The digital biology revolution was not merely a parade of wonders. It was a renegotiation of power over bodies, minds and futures.
The same tools that could make healthcare cheaper and more precise could also deepen inequality or normalize surveillance at the molecular level. The same open-source ethos that empowered garage biohackers could bypass safeguards. The same dream of self-directed evolution could become, under commercial or political pressure, a new obligation to optimize.
Yet Sotiriadis did not dwell in dystopia. Her instinct was to insist on participation rather than retreat. If biology was becoming programmable, then the ethical answer was not ignorance but literacy.
Hacking The Brain, Rewriting The Human Horizon
Toward the close of her presentation, Sotiriadis widened the aperture further, moving from genomes to cognition. Brain-computer interfaces, she suggested, would soon reshape communication, health and self-regulation. Many of the wearables people used today could evolve into implantables tomorrow: internal systems measuring glucose, vital signs and cellular shifts, sending streams of information to medical platforms in real time.
From there, she advanced a still more provocative idea. Biohacking would not stop at treating disease. It would move into enhancement, into mood regulation, into the management of attention and motivation. Human beings, already profoundly shaped by the devices in their pockets, would increasingly seek more direct routes into the circuitry of the brain.
This was not presented as fantasy. It was presented as trajectory.
“The biggest innovations of the twenty-first century will be at the interface of technology and biology,” Sotiriadis said. “A new era is beginning.”
A Revolution Still Taking Shape
What lingered after Elsa Sotiriadis’s appearance at Biohacker Summit 2018 Stockholm was not just the spectacle of possibility, though there was plenty of that. It was the sense that biology had crossed a conceptual border. No longer only the domain of medicine, farming or academic science, it was emerging as a platform technology, one that could reorder food systems, manufacturing, diagnostics, design and even the boundaries of the self.
Much of what she described remained aspirational, experimental or contested. But that was, in a way, beside the point. Revolutions are rarely visible first in finished products. They appear in the change of language, in the shift from observing a system to imagining how to build with it.
At Biohacker Summit 2018 Stockholm, Sotiriadis argued that this shift had already happened. Biology was no longer simply alive. It was becoming writable.
Part of Biohacker Summit 2018 Stockholm